Ameren (AEE) EBITDA (2009 - 2026)

Ameren's EBITDA history runs 18 years deep, the most recent figure standing at $356.0 million for Q1 2026.

• In Q1 2026, EBITDA rose 24.91% year-over-year to $356.0 million; the TTM figure through Mar 2026 stood at $1.5 billion (up 26.36% YoY), while the FY2025 annual figure was $1.5 billion, up 23.69% from the prior year.
• EBITDA was $356.0 million for Q1 2026 at Ameren, up from $262.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $640.0 million in Q3 2025 to a low of $149.0 million in Q4 2022.
• Historically, EBITDA has averaged $306.3 million across 5 years, with a median of $262.0 million in 2025.
• The sharpest annual moves came in 2024 and 2025: EBITDA declined 7.51% in 2024, then soared 40.35% in 2025.
• A 5-year view of EBITDA shows it stood at $149.0 million in 2022, then climbed by 2.01% to $152.0 million in 2023, then soared by 38.82% to $211.0 million in 2024, then increased by 24.17% to $262.0 million in 2025, then soared by 35.88% to $356.0 million in 2026.
• The last three EBITDA figures came in at $356.0 million (Q1 2026), $262.0 million (Q4 2025), and $640.0 million (Q3 2025), per Business Quant data.